WO2023165839 - A DELIVERY SITE DETECTOR AND A MEDICAMENT DELIVERY DEVICE THAT COMPRISES THE DELIVERY SITE DETECTOR

National phase entry:
Publication Number WO/2023/165839
Publication Date 07.09.2023
International Application No. PCT/EP2023/054238
International Filing Date 20.02.2023
Title **
[English] A DELIVERY SITE DETECTOR AND A MEDICAMENT DELIVERY DEVICE THAT COMPRISES THE DELIVERY SITE DETECTOR
[French] DÉTECTEUR DE SITE D’ADMINISTRATION ET DISPOSITIF D’ADMINISTRATION DE MÉDICAMENT QUI COMPREND LE DÉTECTEUR DE SITE D’ADMINISTRATION
Applicants **
SHL MEDICAL AG Gubelstrasse 22, PO Box 7710 6302 Zug, CH
Inventors
SONG, Yu-Lin 6F., No. 116, Touxing St., Xinzhuang Dist. 242041 New Taipei City, TW
TU, Shih-Hsun No 36 Liufu Rd, Luzhu District 338 Taoyuan City, TW
HU, Pei-Chi No 36 Liufu Rd, Luzhu District 338 Taoyuan City, TW
LEE, Chun-Yi No 36 Liufu Rd, Luzhu District 338 Taoyuan City, TW
STIEGLER, Alexander No 36 Liufu Rd, Luzhu District 338 Taoyuan City, TW
Priority Data
63/316,021   03.03.2022   US
22191127.4   19.08.2022   EP
front page image
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
*
International Searching Authority
*
Applicant's Legal Status
*
*
*
*
*
Entry into National Phase under
*
Translation

Recalculate

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing1184
EPO Filing, Examination4675
Japan Filing594
South Korea Filing608
USA Filing, Examination2710
MasterCard Visa

Total: 9771

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Abstract[English] A delivery site detector configured to be attached to a medicament delivery device, the delivery site detector comprising: an ultrasonic transmitter and an ultrasonic receiver; wherein the ultrasonic transmitter is configured to transmit an ultrasonic wave to a delivery site; wherein the ultrasonic receiver is configured to receive an ultrasonic wave reflected by the delivery site; and wherein the ultrasonic transmitter comprises a frequency generator configured to generate and transmit ultrasonic waves with at least two different ultrasound frequencies.[French] Détecteur de site d’administration conçu pour être fixé à un dispositif d’administration de médicament, le détecteur de site d’administration comprenant : un émetteur ultrasonore et un récepteur ultrasonore ; l'émetteur ultrasonore étant configuré pour émettre une onde ultrasonore vers un site d’administration ; le récepteur ultrasonore étant configuré pour recevoir une onde ultrasonore reflétée par le site d’administration ; et l'émetteur ultrasonore comprenant un générateur de fréquence configuré pour générer et émettre des ondes ultrasonores avec au moins deux fréquences ultrasonores différentes.
An unhandled error has occurred. Reload 🗙